Ionis Pharmaceuticals Inc (FRA:ISI)
€ 33.48 -0.13 (-0.39%) Market Cap: 5.40 Bil Enterprise Value: 4.42 Bil PE Ratio: 0 PB Ratio: 8.55 GF Score: 60/100

Ionis Pharmaceuticals Inc at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 04:20PM GMT
Release Date Price: €54.07 (-1.67%)
David Neil Lebowitz
Morgan Stanley, Research Division - VP

Thank you very much for attending the Morgan Stanley Healthcare Conference. Before I get started, I'm going to go through the requisite disclosures. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at www.morganstanley.com/researchdisclosures or at the registration desk.

And I'd like to welcome to the stage with us from Ionis Pharmaceuticals is the COO, Brett Monia; and CFO, Brett -- Beth Hougen. Of course, Ionis is a leader in RNA medicine. And frankly, they have a very, very broad, broad pipeline of drugs. What's the count at now?

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, COO, Senior VP of Translational Medicine & Director

40-plus in the pipeline.

David Neil Lebowitz
Morgan Stanley, Research Division - VP

40 plus, I always lose

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot